Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy

Oct. 9, 2014

Scientists at Roche synthesize novel autotaxin inhibitors

Oct. 9, 2014

DiscoveryBioMed receives grant for ADPKD drug development

Oct. 8, 2014

Linagliptin as potential treatment for uremic calcification

Oct. 3, 2014

Dimerix Bioscience receives approval to begin phase II trial of DMX-200

Oct. 2, 2014

CB2 agonists show potential for the treatment of kidney disease

Sep. 9, 2014

FDA approves Keryx Biopharmaceuticals' ferric citrate

Sep. 8, 2014

Tricida confirms new clinical candidate for cardiorenal disease

Sep. 8, 2014

Velphoro receives marketing authorization in Europe

Aug. 28, 2014

La Jolla Pharmaceutical initiates phase I/II trial of LJPC-501 in hepatorenal syndrome

Aug. 26, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...